Durvalumab and Olaparib
About
Membership operator: AND
Therapies: 2
Therapies
Durvalumab (tx:ncit:C103194)
Olaparib (tx:ncit:C71721)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | pMMR | Endometrial Carcinoma | Durvalumab, Olaparib |